BrightSpring Health Services, Inc. (BTSG) FY2026 YTD Q2 Statement of Cash Flows

Statement of Cash Flows

2026-01-01 to 2026-06-30

Swipe to see the full flow
BrightSpring Health Services, Inc. cash flow reconciliation, Jan 1, 2026 through Jun 30, 2026One connected Sankey reconciles operating, investing and financing net cash flows through a shared cash pool, from beginning cash to ending cash. Ribbons flow left to right on one dollar scale. Activity totals are dark gray; beginning and ending cash are blue. Cash basis for beginning and ending balances and net cash change: Cash, cash equivalents, and restricted cash, including disposal groups and discontinued operations. Intermediate calculation bars are lighter gray. Net income is green for profit and red for loss. Identified asset purchases, sales and maturities are blue in either cash direction. Purple identifies capital transactions such as borrowing, repayments, share issuance and dividends. Free cash flow is a separate comparison, not an added cash flow. Read chart description and values below for full signed amounts, including zero items.Net income → Net cash from operating activities: $166,859,000.00Net income → Operating adjustments reconciliation: $65,960,000.00Inventories → Operating adjustments reconciliation: $239,989,000.00Depreciation and amortization → Operating adjustments reconciliation: $80,517,000.00Accrued expenses → Operating adjustments reconciliation: $27,951,000.00Share-based compensation → Operating adjustments reconciliation: $23,169,000.00Provision for credit losses → Operating adjustments reconciliation: $22,865,000.00Amortization of deferred debt issuance costs → Operating adjustments reconciliation: $5,764,000.00Other → Operating adjustments reconciliation: $1,014,000.00Operating adjustments reconciliation → Accounts receivable: $152,577,000.00Operating adjustments reconciliation → Gain on sale of discontinued operations: $101,868,000.00Operating adjustments reconciliation → Trade accounts payable: $87,503,000.00Operating adjustments reconciliation → Prepaid expenses and other current assets: $86,132,000.00Operating adjustments reconciliation → Other assets and liabilities: $29,620,000.00Operating adjustments reconciliation → Deferred income taxes, net: $9,529,000.00Proceeds from sale of discontinued operations → investing reconciliation: $810,908,000.00Other → investing reconciliation: $1,066,000.00investing reconciliation → Net cash from investing activities: $719,195,000.00investing reconciliation → Purchases of property and equipment: $50,576,000.00investing reconciliation → Acquisitions of businesses: $42,203,000.00Net cash used in financing activities → financing reconciliation: $424,150,000.00Proceeds from shares issued under share-based compensation plan → financing reconciliation: $32,415,000.00financing reconciliation → Long-term debt repayments: $320,491,000.00financing reconciliation → Repurchases of shares of common stock: $120,000,000.00financing reconciliation → Taxes paid related to net share settlement of equity awards: $6,607,000.00financing reconciliation → Payments of financing lease obligations: $5,822,000.00financing reconciliation → Payments of debt issuance costs: $3,378,000.00financing reconciliation → Purchase of redeemable noncontrolling interest: $267,000.00Beginning cash: Cash, cash equivalents, and restricted cash, including disposal groups and discontinued operations → Cash sources and uses: $88,477,000.00Net cash from operating activities → Cash sources and uses: $166,859,000.00Net cash from investing activities → Cash sources and uses: $719,195,000.00Cash sources and uses → Ending cash: Cash, cash equivalents, and restricted cash, including disposal groups and discontinued operations: $550,381,000.00Cash sources and uses → Net cash used in financing activities: $424,150,000.00Net income: $232,819,000.00Net income+$232.82 MDepreciation and amortization: $80,517,000.00Depreciation & amortization+$80.52 MProvision for credit losses: $22,865,000.00Loan loss provision+$22.87 MAmortization of deferred debt issuance costs: $5,764,000.00Debt issuance cost amortization+$5.76 MShare-based compensation: $23,169,000.00Stock-based compensation+$23.17 MDeferred income taxes, net: -$9,529,000.00Deferred income taxes, net−$9.53 MGain on sale of discontinued operations: -$101,868,000.00Discontinued ops gain & loss−$101.87 MOther: $1,014,000.00Other non-cash items+$1.01 MAccounts receivable: -$152,577,000.00Accounts receivable−$152.58 MPrepaid expenses and other current assets: -$86,132,000.00Prepaid & other assets−$86.13 MInventories: $239,989,000.00Inventories+$239.99 MTrade accounts payable: -$87,503,000.00Trade payables−$87.50 MAccrued expenses: $27,951,000.00Accrued liabilities+$27.95 MOther assets and liabilities: -$29,620,000.00Other working capital, net−$29.62 MNet cash from operating activities: $166,859,000.00Operating cash+$166.86 MOperating adjustments reconciliation: $467,229,000.00Long-term debt repayments: -$320,491,000.00Long-term debt repaid−$320.49 MPayments of debt issuance costs: -$3,378,000.00Debt issuance costs−$3.38 MTaxes paid related to net share settlement of equity awards: -$6,607,000.00Stock-award tax withholding−$6.61 MProceeds from shares issued under share-based compensation plan: $32,415,000.00Employee stock plans & options+$32.42 MPurchase of redeemable noncontrolling interest: -$267,000.00Redeemable minority buybacks−$267.00 KRepurchases of shares of common stock: -$120,000,000.00Common stock repurchases−$120.00 MPayments of financing lease obligations: -$5,822,000.00Finance lease payments−$5.82 MNet cash used in financing activities: -$424,150,000.00. Cash required to fund net payments.Financing cash−$424.15 Mfinancing reconciliation: $456,565,000.00Purchases of property and equipment: -$50,576,000.00PP&E purchases−$50.58 MAcquisitions of businesses: -$42,203,000.00Acquisitions, net of cash−$42.20 MProceeds from sale of discontinued operations: $810,908,000.00Business sales+$810.91 MOther: $1,066,000.00Other investing, net+$1.07 MNet cash from investing activities: $719,195,000.00Investing cash+$719.20 Minvesting reconciliation: $811,974,000.00Cash sources and uses: $974,531,000.00Beginning cash: Cash, cash equivalents, and restricted cash, including disposal groups and discontinued operations: $88,477,000.00Beginning cash$88.48 MEnding cash: Cash, cash equivalents, and restricted cash, including disposal groups and discontinued operations: $550,381,000.00Ending cash$550.38 MCASH RECONCILIATIONOperatingflowsInvestingflowsFinancingflowsFree cash flow$116.28 MOperating cash − cash spent on PP&ECash flow / Net income0.72×Operating cash flow ÷ net incomeNet cash change+$461.90 MEnding cash − beginning cash
Chart details

BrightSpring Health Services, Inc. cash flow reconciliation, Jan 1, 2026 through Jun 30, 2026

Cash flows for Jan 1, 2026 through Jun 30, 2026. Cash basis: Cash, cash equivalents, and restricted cash, including disposal groups and discontinued operations. Beginning cash: Dec 31, 2025. Ending cash: Jun 30, 2026. Beginning and ending cash are dated balances. Positive cash flows add cash; negative cash flows reduce it.

Beginning cash on Dec 31, 2025
88,477,000 US dollars. Beginning cash: Cash, cash equivalents, and restricted cash, including disposal groups and discontinued operations
Operating activities
166,859,000 US dollars. Net cash provided.
Net income
232,819,000 US dollars
Depreciation and amortization
80,517,000 US dollars
Provision for credit losses
22,865,000 US dollars
Amortization of deferred debt issuance costs
5,764,000 US dollars
Share-based compensation
23,169,000 US dollars
Deferred income taxes, net
negative 9,529,000 US dollars
Gain on sale of discontinued operations
negative 101,868,000 US dollars
Other
1,014,000 US dollars
Accounts receivable
negative 152,577,000 US dollars
Prepaid expenses and other current assets
negative 86,132,000 US dollars
Inventories
239,989,000 US dollars
Trade accounts payable
negative 87,503,000 US dollars
Accrued expenses
27,951,000 US dollars
Other assets and liabilities
negative 29,620,000 US dollars
Investing activities
719,195,000 US dollars. Net cash provided.
Purchases of property and equipment
negative 50,576,000 US dollars
Acquisitions of businesses
negative 42,203,000 US dollars
Proceeds from sale of discontinued operations
810,908,000 US dollars
Other
1,066,000 US dollars
Financing activities
negative 424,150,000 US dollars. Net cash used.
Long-term debt repayments
negative 320,491,000 US dollars
Payments of debt issuance costs
negative 3,378,000 US dollars
Taxes paid related to net share settlement of equity awards
negative 6,607,000 US dollars
Proceeds from shares issued under share-based compensation plan
32,415,000 US dollars
Purchase of redeemable noncontrolling interest
negative 267,000 US dollars
Repurchases of shares of common stock
negative 120,000,000 US dollars
Payments of financing lease obligations
negative 5,822,000 US dollars
Operating adjustment reconciliation
467,229,000 US dollars. Intermediate calculation joining the operating reconciliation branches. Its gross amount includes any portion of net income routed through this junction. It is not an additional cash source or use.
financing gross reconciliation
456,565,000 US dollars. Gross amount at the activity's junction before offsetting its receipts and deductions. It is not an additional cash source or use.
investing gross reconciliation
811,974,000 US dollars. Gross amount at the activity's junction before offsetting its receipts and deductions. It is not an additional cash source or use.
Exchange-rate effect
0 US dollars
Ending cash on Jun 30, 2026
550,381,000 US dollars. Ending cash: Cash, cash equivalents, and restricted cash, including disposal groups and discontinued operations
Cash sources and uses
974,531,000 US dollars. Opening cash plus net sources, equal to net uses plus ending cash.
Net cash change
461,904,000 US dollars. Ending cash minus beginning cash.
Cash flow / Net income
0.72×. Operating cash flow divided by reconciliation net income for the same period. Black from 0.90× through 1.10×; green above 1.10×; red below 0.90×. Color uses the unrounded ratio.
Operating cash flow
166,859,000 US dollars. Operating cash flow used in the free cash flow calculation.
Cash purchases of property, plant and equipment
50,576,000 US dollars. These cash purchases are already included in investing activities above.
Free cash flow
116,283,000 US dollars. A supplemental measure; finance-lease payments are excluded from this definition.

Chart connections

  • Beginning cash plus operating, investing and financing cash flows plus the exchange-rate effect equals ending cash. Negative amounts reduce cash.
  • Financing contributions meet at a reconciliation junction before connecting to the net cash total.
  • Investing contributions meet at a reconciliation junction before connecting to the net cash total.
  • Operating reconciliation adjustments are not all independent cash receipts.
  • Net income exceeds operating cash. The diagram allocates $166.86M of net income directly to operating cash and $65.96M to the adjustment junction, where it combines with other additions to reconcile deductions. This is an accounting presentation, not a tracing of cash receipts.
  • Each activity has one net cash bar connected to the shared cash pool. Positive activity totals enter the pool; negative activity totals leave the pool to fund that activity's net payments. The central pool does not assign a particular funding source to a particular payment.
  • The intermediate calculation bars include both sides of the displayed activity breakdowns; they are not additional cash flows.
  • Operating cash flow minus cash purchases of property, plant and equipment equals free cash flow: 166,859,000 US dollars minus 50,576,000 US dollars equals 116,283,000 US dollars.
BrightSpring Health Services, Inc. (BTSG) FY2026 YTD Q2 Statement of Cash Flows Sankey chart
Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG

Newsletter

Get the teardowns by email

Subscribe if you want the public-company teardowns in your inbox when they're released.

Product waitlist

Health Check and Teardown for your own company

A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!